DekaBank Deutsche Girozentrale’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $687K | Hold |
73,765
| – | – | ﹤0.01% | 930 |
|
|
2025
Q1 | $573K | Hold |
73,765
| – | – | ﹤0.01% | 948 |
|
|
2024
Q4 | $560K | Hold |
73,765
| – | – | ﹤0.01% | 979 |
|
|
2024
Q3 | $557K | Hold |
73,765
| – | – | ﹤0.01% | 994 |
|
|
2024
Q2 | $448K | Hold |
73,765
| – | – | ﹤0.01% | 1026 |
|
|
2024
Q1 | $375K | Hold |
73,765
| – | – | ﹤0.01% | 1055 |
|
|
2023
Q4 | $454K | Hold |
73,765
| – | – | ﹤0.01% | 1059 |
|
|
2023
Q3 | $532K | Hold |
73,765
| – | – | ﹤0.01% | 1004 |
|
|
2023
Q2 | $512K | Hold |
73,765
| – | – | ﹤0.01% | 1020 |
|
|
2023
Q1 | $594K | Hold |
73,765
| – | – | ﹤0.01% | 983 |
|
|
2022
Q4 | $811K | Hold |
73,765
| – | – | ﹤0.01% | 935 |
|
|
2022
Q3 | $895K | Hold |
73,765
| – | – | ﹤0.01% | 897 |
|
|
2022
Q2 | $781K | Hold |
73,765
| – | – | ﹤0.01% | 928 |
|
|
2022
Q1 | $1.21M | Buy |
73,765
+6,700
| +10% | +$110K | ﹤0.01% | 872 |
|
|
2021
Q4 | $894K | Buy |
67,065
+1,800
| +3% | +$24K | ﹤0.01% | 957 |
|
|
2021
Q3 | $924K | Hold |
65,265
| – | – | ﹤0.01% | 923 |
|
|
2021
Q2 | $995K | Hold |
65,265
| – | – | ﹤0.01% | 910 |
|
|
2021
Q1 | $643K | Sell |
65,265
-40,000
| -38% | -$394K | ﹤0.01% | 984 |
|
|
2020
Q4 | $734K | Sell |
105,265
-75,000
| -42% | -$523K | ﹤0.01% | 939 |
|
|
2020
Q3 | $711K | Buy |
+180,265
| New | +$711K | ﹤0.01% | 852 |
|
|
2019
Q4 | – | Sell |
-31,500
| Closed | -$100K | – | 1148 |
|
|
2019
Q3 | $100K | Sell |
31,500
-31,500
| -50% | -$100K | ﹤0.01% | 910 |
|
|
2019
Q2 | $229K | Buy |
63,000
+24,500
| +64% | +$89.1K | ﹤0.01% | 1003 |
|
|
2019
Q1 | $276K | Buy |
38,500
+7,000
| +22% | +$50.2K | ﹤0.01% | 1000 |
|
|
2018
Q4 | $251K | Sell |
31,500
-7,000
| -18% | -$55.8K | ﹤0.01% | 935 |
|
|
2018
Q3 | $276K | Sell |
38,500
-1,000
| -3% | -$7.17K | ﹤0.01% | 1022 |
|
|
2018
Q2 | $229K | Hold |
39,500
| – | – | ﹤0.01% | 1028 |
|
|
2018
Q1 | $189K | Buy |
+39,500
| New | +$189K | ﹤0.01% | 993 |
|
|
2016
Q2 | – | Sell |
-35,000
| Closed | -$96K | – | 993 |
|
|
2016
Q1 | $96K | Sell |
35,000
-2,000
| -5% | -$5.49K | ﹤0.01% | 966 |
|
|
2015
Q4 | $388K | Buy |
37,000
+500
| +1% | +$5.24K | ﹤0.01% | 739 |
|
|
2015
Q3 | $416K | Buy |
36,500
+1,500
| +4% | +$17.1K | 0.01% | 729 |
|
|
2015
Q2 | $523K | Buy |
35,000
+1,300
| +4% | +$19.4K | 0.01% | 693 |
|
|
2015
Q1 | $304K | Sell |
33,700
-4,900
| -13% | -$44.2K | ﹤0.01% | 820 |
|
|
2014
Q4 | $467K | Sell |
38,600
-3,500
| -8% | -$42.3K | 0.01% | 707 |
|
|
2014
Q3 | $412K | Buy |
42,100
+2,100
| +5% | +$20.6K | 0.01% | 699 |
|
|
2014
Q2 | $510K | Buy |
40,000
+3,500
| +10% | +$44.6K | 0.01% | 596 |
|
|
2014
Q1 | $386K | Buy |
+36,500
| New | +$386K | 0.01% | 620 |
|